Insights

Health Care Compliance and Enforcement Update

This issue of the Jones Day Health Care Compliance and Enforcement Update covers judicial, legislative, and regulatory matters affecting health care entities, along with other important developments in the second and third quarters of 2012.

In this issue:

Judicial Developments

"GlaxoSmithKline Pays $3 Billion Health Care Fraud Settlement"
"Janssen Pharmaceuticals Enters into Consent Decree with States and Settles Consumer Protection Claims"
"D.C. Circuit Rules that Discretionary Exclusion Period Under Responsible Corporate Officer Doctrine Must Be Supported by Substantial Evidence"

Regulatory and Legislative Developments

"Public–Private Initiative Formed to Prevent Health Care Fraud"
"CMS Delays Implementation of ICD-10"
"Senators Urge CMS to 'Let the Sunshine In' and Implement the Physician Payments Sunshine Act"
"Lawmakers Investigate 340B Drug Discount Program"

Developments Involving Providers

"Recovery Audit Contractors"
"Home Health"
"Nursing Home"
"Pharmacy"
"Corporate Integrity Agreement Enforcement"

International Developments

"European Commission Considers Reforms to EU Clinical Trials"
"German Court Re-Enforces Incentives Ban Against Manufacturer: No Touchpads for Increased Sales"

Jones Day News

"Former Chief of the Major Frauds Section for U.S. Attorney's Office (C.D. Cal.) Joins Jones Day"

View the newsletter here.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.